Avanu SPRL
The score of Avanu shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +38 % Total assets +3 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Avanu's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 12 Nov 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 23 Aug 2023
- Year ended 31 Dec 2021filed on 27 Sep 2022
Avanu's financial analysis
- Solvency18.4%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Avanu
Avanu's publications in the Belgian Gazette
No Belgian Gazette publication known for this company.
Company number, VAT number and registered office
- Company number (CBE)
- 0871.421.670
- VAT number
- BE0871421670
- Peppol
- Registered · 0208:0871421670 · as of 04 Nov 2026
- Legal form
- SPRL
- Incorporated
- 25 Jan 2005
- Registered office
- 9300 Aalst
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Avanu (SPRL) has been based in Aalst since 2005, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 4,588 € and equity of 100,176 €; its revenue is not published. Its solvency stands at 18.4%, below the median of its sector (44.0%).
Companies similar to Avanu
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Antwer Retail sale of pharmaceutical products Wervik · balance sheet 548,543 €
- La Grande Pharmacie Retail sale of pharmaceutical products Thimister-Clermont · balance sheet 539,236 €
- Vereenooghe OST Retail sale of pharmaceutical products Ostend · balance sheet 553,755 €
- Farmadec Retail sale of pharmaceutical products Asse · balance sheet 554,731 €
- Farma DE Heide Retail sale of pharmaceutical products Londerzeel · balance sheet 529,320 €
- Sana SP Retail sale of pharmaceutical products Staden · balance sheet 527,924 €
- Apotheek D'HEER Pharma Retail sale of pharmaceutical products Lokeren · balance sheet 563,573 €
Frequently asked questions about Avanu
What is the revenue of Avanu?
Avanu files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Avanu?
In Belgium, the VAT number is the company number prefixed with BE: BE0871421670 for Avanu, if the company is VAT-registered. Its company number (CBE) is 0871.421.670.
Where is the registered office of Avanu?
According to the CBE register, the registered office of Avanu is in 9300 Aalst.
What is the equity of Avanu?
At the close of the 2025 financial year, the equity of Avanu amounts to 100,176 €, a solvency of 18.4% of total assets.
Who manages Avanu?
The register lists 3 active mandates at Avanu. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Avanu
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →